Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence

Journal of Neurosurgery

Volumn 97, Issue 4, 2002, Pages 794-802

  McKnight, Tracy R ^a   Von dem Bussche, Mary H ^a   Vigneron, Daniel B ^a   Lu, Ying ^a   Berger, Mitchel S ^a   McDermott, Michael W ^a   Dillon, William P ^a   Graves, Edward E ^a   Pirzkall, Andrea ^a   Nelson, Sarah J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopsy; Brain; Choline; Glioma; Magnetic resonance spectroscopy; N acetylaspartate

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SURGICAL TECHNIQUE; TISSUE DISTRIBUTION; TUMOR BIOPSY; VALIDATION PROCESS;

EID: 0036801611     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.97.4.0794     Document Type: Article

References (26)

1. Burtscher IM, Skagerberg G, Geijer B, et al: Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR 21:84-93, 2000
2. Butzen J, Prost R, Chetty V, et al: Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: The limits of accuracy with a logistic regression model. AJNR 21:1213-1219, 2000
3. Croteau D, Scarpace L, Hearshen D, et al: Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: Semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49:823-829, 2001
4. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845, 1988
5. Diggle PJ, Liang KY, Zeger SL: Analysis of Longitudinal Data. Oxford: Clarendon Press, 1996, p 253
6. Dowling C, Bollen AW, Noworolski SM, et al: Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopathologic analysis of resection specimens. AJNR 22:604-612, 2001
7. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. New York: Chapman & Hall, 1993, pp xvi, 436
8. Graves EE, Nelson SJ, Vigneron DB, et al: A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46:319-328, 2000
9. Gupta RK, Cloughesy TF, Sinha U, et al: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215-226, 2000
10. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 33:255-268, 1993
11. Kurhanewicz J, Vigneron DB, Nelson SJ: Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2:166-189, 2000
12. McKnight TR, Noworolski SM, Vigneron DB, et al: An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 13:167-177, 2001
13. Meyerand ME, Pipas JM, Mamourian A, et al: Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR 20:117-123, 1999
14. Nelson SJ: Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 46:228-239, 2001
15. Nelson SJ, Huhn S, Vigneron DB, et al: Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: Presentation of a detailed case study. J Magn Reson Imaging 7:1146-1152, 1997
16. Nelson SJ, Vigneron DB, Dillon WP: Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed 12:123-138, 1999
17. Patel S, McKnight TR, Nelson SJ, et al: Metabolic characteristics within the T2 abnormality associated with primary brain tumors as determined by 3-D proton MR spectroscopic imaging. Radiology 213 (Suppl):187, 1999 (Abstract)
18. Pirzkall A, McKnight TR, Graves EE, et al: MR-spectroscopy guided target delineation for high grade gliomas. Int J Radiat Oncol Biol Phys 50:915-928, 2001
19. Preul MC, Caramanos Z, Collins DL, et al: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325, 1996
20. Roberts TP, Ferrari P, Perry D, et al: Presurgical mapping with magnetic source imaging: Comparisons with intraoperative findings. Brain Tumor Pathol 17:57-64, 2000
21. Shimizu H, Kumabe T, Shirane R, et al: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR 21:659-665, 2000
22. Star-Lack J, Vigneron DB, Pauly J, et al: Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging 7:745-757, 1997
23. Szymanski MD, Perry DW, Gage NM, et al: Magnetic source imaging of late evoked field responses to vowels: Toward an assessment of hemispheric dominance for language. J Neurosurg 94:445-453, 2001
24. Tran TK, Vigneron DB, Sailasuta N, et al: Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 43:23-33, 2000
25. Usenius JP, Tuohimetsä S, Vainio P, et al: Automated classification of human brain tumors by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. Neuroreport 7:1597-1600, 1996
26. Vigneron D, Bollen A, McDermott M, et al: Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 19:89-101, 2001